Latest filing published 18 Dec 2006 for Oncotelic Therapeutics, Inc., €248k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -11.8%Entry US$1,012.80 · Close at T+365 US$892.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Per Olof Soderberg: trading record in brief
Per Olof Soderberg is a declared insider of Oncotelic Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 15 March 2006 to 15 December 2006, the count stands at 6 filings.
No open-market sale appears; the market trades are 5 purchases worth €1.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €164k.
The latest filing, published on 18 December 2006, reports an open-market purchase of €248k in Oncotelic Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Per Olof Soderberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 65,800 shares@ US$4.94Common StockSEC:0001181431-06-070267:0Canonical exit: 15 Mar 2007 (T+90)
- 100,000 shares@ US$5.02Common StockSEC:0001181431-06-068137:0Canonical exit: 5 Mar 2007 (T+90)
- 20,000 sharesCommon StockSEC:0001181431-06-063336:0
- 30,800 shares@ US$3.43Common StockSEC:0001181431-06-050595:0Canonical exit: 28 Nov 2006 (T+90)
- 53,400 shares@ US$3.53Common StockSEC:0001181431-06-050595:1Canonical exit: 29 Nov 2006 (T+90)
- 50,000 shares@ US$3.95Common StockSEC:0001181431-06-018767:0Canonical exit: 13 Jun 2006 (T+90)
6 of 6 declarations
